Cargando…
DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy
INTRODUCTION: Damage specific DNA binding protein 2 (DDB2) is an UV-indiced DNA damage recognition factor and regulator of cancer development and progression. DDB2 has dual roles in several cancers, either as an oncogene or as a tumor suppressor gene, depending on cancer localization. Here, we inves...
Autores principales: | Dardare, Julie, Witz, Andréa, Betz, Margaux, Francois, Aurélie, Meras, Morgane, Lamy, Laureline, Lambert, Aurélien, Grandemange, Stéphanie, Husson, Marie, Rouyer, Marie, Demange, Jessica, Merlin, Jean-Louis, Harlé, Alexandre, Gilson, Pauline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773984/ https://www.ncbi.nlm.nih.gov/pubmed/36568213 http://dx.doi.org/10.3389/fonc.2022.1052163 |
Ejemplares similares
-
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
por: Witz, Andréa, et al.
Publicado: (2023) -
Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers
por: Gilson, Pauline, et al.
Publicado: (2023) -
SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
por: Dardare, Julie, et al.
Publicado: (2020) -
Emerging Roles of DDB2 in Cancer
por: Gilson, Pauline, et al.
Publicado: (2019) -
ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
por: Betz, Margaux, et al.
Publicado: (2023)